APA (7th ed.) Citation

M, E., U, K., D, C., E, B., D, B., O, B., . . . MH, Y. (2026). Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: A multicenter retrospective study. Frontiers in immunology, 17, 1714533. https://doi.org/10.3389/fimmu.2026.1714533

Chicago Style (17th ed.) Citation

M, Ersoy, et al. "Baseline Glucose-to-lymphocyte Ratio Predicts Nivolumab Outcomes in Advanced Non-small Cell Lung Cancer: A Multicenter Retrospective Study." Frontiers in Immunology 17 (2026): 1714533. https://doi.org/10.3389/fimmu.2026.1714533.

MLA (9th ed.) Citation

M, Ersoy, et al. "Baseline Glucose-to-lymphocyte Ratio Predicts Nivolumab Outcomes in Advanced Non-small Cell Lung Cancer: A Multicenter Retrospective Study." Frontiers in Immunology, vol. 17, 2026, p. 1714533, https://doi.org/10.3389/fimmu.2026.1714533.